1. The effect of porphyrin structure on binding to human serum albumin by fluorescence spectroscopy
- Author
-
Janet Brenton, Amanda Maxwell, Alison Douglas, Joan Widin, Kirsten Indrelie, Olga Rinco, Jacob Wessels, and Michelle Henderson
- Subjects
Hematoporphyrin ,Quenching (fluorescence) ,Protoporphyrin IX ,General Chemical Engineering ,medicine.medical_treatment ,General Physics and Astronomy ,Photodynamic therapy ,General Chemistry ,Photochemistry ,Human serum albumin ,Porphyrin structure ,Fluorescence ,Fluorescence spectroscopy ,body regions ,chemistry.chemical_compound ,chemistry ,embryonic structures ,polycyclic compounds ,medicine ,heterocyclic compounds ,medicine.drug - Abstract
The efficacy of porphyrin binding to human serum albumin (HSA) is critical to clinical use in photodynamic therapy (PDT). Several porphyrins were utilized to measure the effect of porphyrin structure on its binding to HSA. Two categories of porphyrins were utilized: porphyrins with a hydrophobic and hydrophilic side: Protoporphyrin IX (PPIX), Protoporphyrin IX dimethylester (PPIXDE), and Chlorin e6 (Ce6) and porphyrins with hydrophilic substituents on both sides: Hematoporphyrin IX (Hme), Hematoporphyrin IX dimethylester (HmeDE), and Deuteroporphyrin IX dimethylester (DPIXEG). The following methods were used for the analysis: Stern–Volmer quenching, fluorescence lifetimes, anisotropy, fluorescence binding, and homogeneous studies. The results indicate that PPIX, PPIXDE, and Ce6 bind to HSA efficiently, evidence that porphyrins bind strongly to HSA if they have a hydrophobic and hydrophilic side. Hme is thought to bind to HSA but likely to a lesser degree than the aforementioned three porphyrins. HmeDE and DPIXEG seem not to bind to HSA probably due to the lack of hydrophobic substituents.
- Published
- 2009
- Full Text
- View/download PDF